Quo vadis blood protein adductomics?
Gabriele Sabbioni1,2, Billy W Day3,4
1Institute of Environmental and Occupational Toxicology, CH-6780, Airolo, Switzerland. gabriele.sabbioni@bluewin.ch.
Archives of Toxicology
|November 13, 2021
Summary
Biomonitoring using blood protein adducts assesses individual chemical exposure and dose. Newer proteomic methods show promise but require further development for sensitive detection of xenobiotic exposure.
Area of Science:
- Environmental Health
- Toxicology
- Biochemistry
Background:
- Chemical exposure is routinely monitored in various environmental and occupational settings.
- Biomonitoring of chemicals in biological fluids helps determine individual exposure levels.
- Blood protein adducts serve as crucial biomarkers for both xenobiotic exposure and biologically effective dose.
Purpose of the Study:
- To review the utility of blood protein adducts as biomarkers for chemical exposure.
- To discuss advancements in analytical methods, including proteomic techniques, for adduct detection.
- To identify current limitations and future directions for improving biomonitoring sensitivity.
Main Methods:
- Analysis of chemical exposure through biomonitoring of biological fluids.
- Quantification of xenobiotic adducts on blood proteins, including hemoglobin.
- Application of proteomic techniques for the analysis of larger adducted peptides.
Main Results:
- Stable hemoglobin adducts provide exposure markers for up to 120 days.
- Proteomic approaches enable the analysis of larger adducted peptides.
- Current methods using larger peptides have detection limits inferior to those for single amino acid or cleaved adducts.
Conclusions:
- Blood protein adducts are valuable markers for assessing chemical exposure and internal dose.
- Proteomic advancements offer new avenues for adduct analysis, but sensitivity needs improvement.
- Further development of analytical methodologies is essential for enhanced biomonitoring capabilities.
More Related Videos
Related Concept Videos
Western Blotting
18.2K
Western blotting is an analytical technique for protein identification. It has various applications in immunology and medicine, including detecting diseases like bovine spongiform encephalopathy, mad cow disease, and human and feline immunodeficiency virus from biological samples.
The technique begins with separating proteins from the sample using sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), followed by protein transfer, immunoblotting, and finally, protein detection.
The technique begins with separating proteins from the sample using sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), followed by protein transfer, immunoblotting, and finally, protein detection.
18.2K
Proteomics
8.5K
A proteome is the entire set of proteins that a cell type produces. We can study proteomes using the knowledge of genomes because genes code for mRNAs, and the mRNAs encode proteins. Although mRNA analysis is a step in the right direction, not all mRNAs are translated into proteins.
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term...
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term...
8.5K
Blood Typing
1.7K
Understanding an individual's blood group is a critical component of transfusion medicine. It ensures compatibility in blood transfusions, organ transplants, and even during pregnancy. Determining these blood groups involves the ABO and Rh blood typing systems, utilizing specific antigens and corresponding anti-sera to identify an individual's blood type.
Antigens are protein molecules that reside on the surface of red blood cells (RBCs). The ABO and Rh blood typing systems target...
Antigens are protein molecules that reside on the surface of red blood cells (RBCs). The ABO and Rh blood typing systems target...
1.7K


